“…AI in PCa has been applied in different settings such as assessment of benign/malignant lesions, to distinguish significant versus non-significant cancer, defining active surveillance candidates, staging, prediction of response to treatment, and recurrence among others [ 46 , 47 , 48 , 49 , 50 ]. In terms of diagnosis, many studies have reported the advantages of different AI models to provide accurate diagnosis of PCa [ 51 , 52 , 53 , 54 , 55 , 56 ].…”